Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis,...
Similar Items
-
Genetically determined telomere length and multiple myeloma risk and outcome
by: Matteo Giaccherini, et al.
Published: (2021-04-01) -
No influence of the polymorphisms <it>CYP2C19 </it>and <it>CYP2D6 </it>on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
by: Vogel Ulla, et al.
Published: (2010-08-01) -
Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
by: Hans E. Johnsen, et al.
Published: (2009-08-01) -
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
by: Henrik Gregersen, et al.
Published: (2018-08-01) -
Making Materials Matter—A Contribution to a Sociomaterial Perspective on Work Environment
by: Johan Simonsen Abildgaard, et al.
Published: (2013-12-01)